Literature DB >> 25416080

A morphometric study of the hepatic arterioles in end-stage primary sclerosing cholangitis.

M Isabel Fiel1, Hamid R Sima, Amirabbas Azarian, Thomas D Schiano.   

Abstract

Primary sclerosing cholangitis (PSC) is typified by a heterogeneous histology with periductal fibroinflammatory lesions. The hepatic arterioles in PSC have not been well characterized. Using image analysis, we sought to examine the dimensions of hepatic arterioles in PSC. We identified 30 livers from patients transplanted for PSC as well as 10 explants each from cirrhotic patients (serving as controls) having primary biliary cirrhosis, hepatitis C (HCV), and alcoholic liver disease. At least two representative hematoxylin and eosin-stained slides were selected, and ten cross-sectioned hepatic arterioles were photographed for image analysis. The vessels were measured at their longest span and width based on the outer portions of the tunica media. Wall thickness was measured at its thickest portion from the intima to the outer portion of the tunica media; the perimeter of the luminal area was outlined by the endothelial lining, generating the total luminal area. Mean arteriolar length, width, and wall thickness (p = 0.012, p = 0.004, p = 0.001, respectively) were greater in the PSC group; luminal area was similar between the groups. When compared to the individual sub-groups, wall thickness of arterioles in PSC remained significantly greater. End-stage PSC has even larger-sized arterioles and greater wall thickness as compared to that of other cirrhotic livers. This increased wall thickness found in PSC cannot be solely attributed to cirrhosis itself. These vessel changes may potentially be the result of, or contribute to, the pathogenesis of PSC.

Entities:  

Mesh:

Year:  2014        PMID: 25416080     DOI: 10.1007/s00428-014-1680-9

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  26 in total

1.  Chemotherapy-induced sclerosing cholangitis: long-term response to endoscopic therapy.

Authors:  Waleed M Alazmi; Lee McHenry; James L Watkins; Evan L Fogel; Suzette Schmidt; Stuart Sherman; Glen L Lehman
Journal:  J Clin Gastroenterol       Date:  2006-04       Impact factor: 3.062

2.  Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers.

Authors:  Tania A Roskams; Neil D Theise; Charles Balabaud; Govind Bhagat; Prithi S Bhathal; Paulette Bioulac-Sage; Elizabeth M Brunt; James M Crawford; Heather A Crosby; Valeer Desmet; Milton J Finegold; Stephen A Geller; Annette S H Gouw; Prodromos Hytiroglou; A S Knisely; Masamichi Kojiro; Jay H Lefkowitch; Yasuni Nakanuma; John K Olynyk; Young Nyun Park; Bernard Portmann; Romil Saxena; Peter J Scheuer; Alastair J Strain; Swan N Thung; Ian R Wanless; A Brian West
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

Review 3.  Regulation of hepatic blood flow: the hepatic arterial buffer response revisited.

Authors:  Christian Eipel; Kerstin Abshagen; Brigitte Vollmar
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

4.  Microvasculature in the small portal tracts in idiopathic portal hypertension. A morphological comparison with other hepatic diseases.

Authors:  T Terada; M Hoso; Y Nakanuma
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

5.  Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.

Authors:  Susan C Abraham; Patrick S Kamath; Bijan Eghtesad; Anthony J Demetris; Alyssa M Krasinskas
Journal:  Am J Surg Pathol       Date:  2006-11       Impact factor: 6.394

Review 6.  Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response.

Authors:  W W Lautt
Journal:  Am J Physiol       Date:  1985-11

7.  Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.

Authors:  I W Graziadei; R H Wiesner; P J Marotta; M K Porayko; J E Hay; M R Charlton; J J Poterucha; C B Rosen; G J Gores; N F LaRusso; R A Krom
Journal:  Hepatology       Date:  1999-11       Impact factor: 17.425

Review 8.  Hepatic blood flow: morphologic aspects and physiologic regulation.

Authors:  A M Rappaport
Journal:  Int Rev Physiol       Date:  1980

Review 9.  Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis.

Authors:  Natalie A Molodecky; Hashim Kareemi; Rohan Parab; Herman W Barkema; Hude Quan; Robert P Myers; Gilaad G Kaplan
Journal:  Hepatology       Date:  2011-05       Impact factor: 17.425

Review 10.  Primary sclerosing cholangitis: diagnosis, prognosis, and management.

Authors:  Siddharth Singh; Jayant A Talwalkar
Journal:  Clin Gastroenterol Hepatol       Date:  2013-02-27       Impact factor: 11.382

View more
  1 in total

Review 1.  Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis.

Authors:  Samantha Sarcognato; Diana Sacchi; Federica Grillo; Nora Cazzagon; Luca Fabris; Massimiliano Cadamuro; Ivana Cataldo; Claudia Covelli; Alessandra Mangia; Maria Guido
Journal:  Pathologica       Date:  2021-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.